Skip to main content


Severe depression during and after pregnancy may be triggered by a runaway inflammatory immune response in some women, according to a new study published online in Brain, Behavior, and Immunity.
A single, low-dose infusion of ketamine produced no significant long-lasting side effects over 3 months of follow-up in patients with treatment-resistant depression, according to a study published online in the Journal of Affective Disorders.
A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances.
Smartphone dependency in adolescents predicts loneliness and depression months later, suggests a study published online in the Journal of Adolescent Health.
Young adults who eat poorly and feel depressed might be able to perk themselves up by switching to a healthier diet, a small study suggests.
Sanjay J. Mathew, MD, speaks about best practices for administering esketamine during his Psych Congress 2019 presentation "Top 5 Issues Clinicians Should Know about Ketamine Therapy."
Two members of the Psych Congress Steering Committee have been featured on an ABC News podcast which grew out of a newsman's newfound interest in meditation.
Listen as Psych Congress Steering Committee member Charles Raison, MD, discusses a book he coauthored, The New Mind-Body Science of Depression, with David Van Nuys, PhD, on Shrink Rap Radio.
Back to Top